Progress in the management of childhood asthma
10.5415/apallergy.2012.2.1.15
- Author:
Pakit VICHYANOND
1
;
Rattana PENSRICHON
;
Suruthai KURASIRIKUL
Author Information
1. Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. sipvy@mahidol.ac.th
- Publication Type:Review
- Keywords:
Asthma;
Children;
β₂-agonist;
Theophylline;
Inhaled corticosteroids;
Sublingual immunotherapy
- MeSH:
Adrenal Cortex Hormones;
Asthma;
Child;
Chronic Disease;
Cockroaches;
Humans;
Mites;
Sublingual Immunotherapy;
Theophylline
- From:
Asia Pacific Allergy
2012;2(1):15-25
- CountryRepublic of Korea
- Language:English
-
Abstract:
Asthma has become the most common chronic disease in childhood. Significant advances in epidemiological research as well as in therapy of pediatric asthma have been made over the past 2 decades. In this review, we look at certain aspects therapy of childhood asthma, both in the past and present. Literature review on allergen avoidance (including mites, cockroach and cat), intensive therapy with β₂-agonists in acute asthma (administering via continuous nebulization and intravenous routes), a revisit of theophylline use and its action, the use of inhaled corticosteroids in various phases of childhood asthma and sublingual immunotherapy in asthma are examined. Recent facts and dilemmas of these treatments are identified along with expression of our opinions, particularly on points of childhood asthma in the Asia-Pacific, are made in this review.
